4.7 Article

Assessment of Lipid Balance Parameters after Laparoscopic Sleeve Gastrectomy in 1-Year Observation

Related references

Note: Only part of the references are listed.
Review Surgery

Endoscopic management of obesity: Impact of endoscopic sleeve gastroplasty on weight loss and co-morbidities at six months and one year

F. Alexandre et al.

Summary: Endoscopic sleeve gastroplasty (ESG) is a new minimally invasive endoscopic treatment that induces weight loss. It has been proven to effectively reduce weight and improve obesity-related co-morbidities at six months and one year. This procedure has the potential to be widely used as an effective treatment for morbid obesity.

JOURNAL OF VISCERAL SURGERY (2023)

Review Surgery

Endoscopic management of obesity: Impact of endoscopic sleeve gastroplasty on weight loss and co-morbidities at six months and one year

F. Alexandre et al.

Summary: This study evaluated the effects of endoscopic sleeve gastroplasty (ESG) on obesity-associated co-morbidities and biological parameters. The results showed that ESG was effective in inducing weight loss and reducing obesity-related co-morbidities. Additionally, significant reductions in blood glucose, liver function, and lipid levels were observed at six and twelve months after the surgery.

JOURNAL OF VISCERAL SURGERY (2023)

Article Endocrinology & Metabolism

Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy

Hans Jorgen Nielsen et al.

Summary: This study compared the long-term outcomes of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) for severe obesity, showing that RYGB resulted in higher weight loss and remission rates of main obesity-related comorbidities, while SG had fewer major early complications.

INTERNATIONAL JOURNAL OF OBESITY (2022)

Article Medicine, General & Internal

Risk Factors for Early and Late Complications after Laparoscopic Sleeve Gastrectomy in One-Year Observation

Paulina Gluszynska et al.

Summary: This study assessed the risk factors for complications after laparoscopic sleeve gastrectomy. The results showed that smoking and hypercholesterolemia were independent risk factors for early complications, while smoking, peptic ulcer diseases, and hiatal hernia were independent predictors of late complications.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Biology

Metabolomic Profiling of Lipids and Fatty Acids: 3 Years Postoperative Laparoscopic Sleeve Gastrectomy

Charu Sharma et al.

Summary: Laparoscopic sleeve gastrectomy (LSG) is an effective bariatric surgery for weight loss, which shows positive impact on blood lipid profile and fatty acid distribution in obese patients even 3 years post-surgery. However, long-term maintenance of overall health would require strict regular follow-up and lifestyle interventions.

BIOLOGY-BASEL (2021)

Article Cardiac & Cardiovascular Systems

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society

Henry N. Ginsberg et al.

Summary: Recent research supports a causal association between triglycerides, triglyceride-rich lipoproteins, and their remnants with cardiovascular diseases, emphasizing the importance of focusing on their impact on heart health. Targeting levels of triglycerides and their remnants may potentially reduce the risk of atherosclerotic cardiovascular diseases.

EUROPEAN HEART JOURNAL (2021)

Review Gastroenterology & Hepatology

Complications associated with laparoscopic sleeve gastrectomy - a review

Paulina Wozniewska et al.

Summary: Laparoscopic sleeve gastrectomy is an important bariatric procedure for obese patients, providing significant weight loss but also carrying risks of complications, both acute and late. Acute complications include bleeding, staple line leaks, and abscess formation, while late complications include gastric stenosis, nutrient deficiencies, mediastinal pouch migration, and development or exacerbation of gastroesophageal reflux diseases. Management of these complications requires prompt attention and treatment.

GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY (2021)

Article Cardiac & Cardiovascular Systems

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society

Henry N. Ginsberg et al.

Summary: This article reviews the impact of triglycerides and triglyceride-rich lipoproteins on cardiovascular disease risk, emphasizing that reducing levels of TRL and their remnants can help reduce the risk of ASCVD.

EUROPEAN HEART JOURNAL (2021)

Review Cell Biology

Transcriptional regulation of hepatic lipogenesis

Yuhui Wang et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)

Review Medicine, General & Internal

Metabolic syndrome: definitions and controversies

Eva Kassi et al.

BMC MEDICINE (2011)